pyrazines has been researched along with Leukemia, T-Cell in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (90.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Z; Gong, S; Guo, L; Lü, S; Wang, J; Yang, J; Zhou, H | 1 |
| Chen, SJ; Chen, Z; Janin, A; Jiang, XX; Shen, ZX; Wang, L; Wu, WL; Yang, F; Zhang, QL; Zhang, YW; Zhao, WL | 1 |
| Gajate, C; Mollinedo, F; Reis-Sobreiro, M | 1 |
| Chen, SJ; Janin, A; Jiang, XX; Leboeuf, C; Shi, WY; Wang, L; Xiao, D; Yang, F; Yao, Y; Zhao, WL | 1 |
| Harding, JC; Hess, JL; Mitra-Kaushik, S; Ratner, L | 1 |
| Aifantis, I; Alegre, ML; Buonamici, S; Ferrando, A; Kee, BL; Macaroun, S; Mandal, M; Mascarenhas, J; Meng, F; Miele, L; Palomero, T; Spaulding, C; Thompson, B; Vilimas, T | 1 |
| Hajduch, M; Kvasnica, M; Sarek, J; Tislerova, I; Urban, M | 1 |
| Au, WY; Guo, T; Kwong, YL; Liang, RH; Shen, L; Srivastava, G; Tsuchiyama, J; Wong, KY; Wong, ML; Yuen, PW | 1 |
| Hamamura, RS; Kobayashi, C; Kurashina, R; Ohyashiki, JH; Ohyashiki, K; Takaku, T; Zhang, Y | 1 |
| Dong, X; Li, X; Stoltz, JF; Wang, X; Zhao, H; Zhu, C; Zhuang, F | 1 |
10 other study(ies) available for pyrazines and Leukemia, T-Cell
| Article | Year |
|---|---|
Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Survival; Chymotrypsin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; K562 Cells; Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Endopeptidase Complex; Pyrazines; Ubiquitin | 2008 |
The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
Topics: Animals; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Leukemia, T-Cell; Lymphoma, T-Cell; Mice; Mice, Nude; Neoplasm Proteins; Protease Inhibitors; Proteasome Inhibitors; Protein Kinases; Pyrazines; Signal Transduction; Vorinostat; Xenograft Model Antitumor Assays | 2009 |
Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Boronic Acids; Bortezomib; Caspase 10; Caspase 8; Cell Line, Tumor; Drug Synergism; fas Receptor; Fas-Associated Death Domain Protein; Flow Cytometry; Fluorescent Antibody Technique; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia, T-Cell; Membrane Microdomains; Microscopy, Confocal; Mitochondria; Multiple Myeloma; Phosphorylcholine; Pyrazines; Resveratrol; Signal Transduction; Stilbenes | 2009 |
Proteasome inhibitor bortezomib targeted tumor-endothelial cell interaction in T-cell leukemia/lymphoma.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Communication; Cell Movement; Endothelial Cells; Enzyme Inhibitors; Humans; Jurkat Cells; Leukemia, T-Cell; Lymphoma, T-Cell; Mice; Mice, Nude; Molecular Targeted Therapy; Proteasome Inhibitors; Pyrazines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Division; Crosses, Genetic; Cysteine Endopeptidases; DNA Replication; Genes, pX; HTLV-I Infections; Humans; Interleukin-10; Interleukin-6; Leukemia, T-Cell; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multienzyme Complexes; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines | 2004 |
Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.
Topics: Animals; Boronic Acids; Bortezomib; CD4 Antigens; CD8 Antigens; Cell Line; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; COS Cells; DNA-Binding Proteins; Gene Expression Profiling; Green Fluorescent Proteins; Humans; Interleukin Receptor Common gamma Subunit; Leukemia, Experimental; Leukemia, T-Cell; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Mutation; NF-kappa B; Pyrazines; Receptor, Notch1; Signal Transduction; Survival Analysis | 2007 |
Triterpenoid pyrazines and benzopyrazines with cytotoxic activity.
Topics: Antineoplastic Agents, Phytogenic; Betulinic Acid; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Leukemia, T-Cell; Molecular Structure; Pentacyclic Triterpenes; Pyrazines; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2007 |
Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation.
Topics: Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Killer Cells, Natural; Leukemia, T-Cell; Lymphoma, T-Cell; Protease Inhibitors; Pyrazines; Tumor Cells, Cultured | 2007 |
Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Boronic Acids; Bortezomib; Electrophoretic Mobility Shift Assay; Gene Expression; Gene Expression Profiling; Heme Oxygenase-1; Humans; I-kappa B Proteins; Leukemia, T-Cell; Mice; NF-kappa B; Oligonucleotide Array Sequence Analysis; Protoporphyrins; Pyrazines; Rats; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Tetramethylpyrazine inhibits phytohemagglutinin-induced upregulation of ICAM-1 and LFA-1 mediated leukocyte adhesion.
Topics: Adult; Cell Adhesion; Drugs, Chinese Herbal; Erythrocyte Deformability; Female; Humans; Image Processing, Computer-Assisted; Intercellular Adhesion Molecule-1; Leukemia, T-Cell; Lymphocyte Activation; Lymphocyte Function-Associated Antigen-1; Male; Micromanipulation; Middle Aged; Phytohemagglutinins; Protein Binding; Protein Conformation; Pyrazines; Structure-Activity Relationship; T-Lymphocytes; Tumor Cells, Cultured | 2000 |